Group 1 - The core point of the article highlights the transfer of shares of Universal Medical (02666) from GF Securities Hong Kong to Cinda International Securities, with a market value of HKD 1.236 billion, representing 9.37% of the total shares [1] - On November 18, 2025, the company signed an agreement to establish a joint venture with China National Machinery New Energy and Helex Technology, with a registered capital of RMB 30 million [1] - The capital contributions to the joint venture are as follows: the company will contribute RMB 15.03 million, China National Machinery New Energy will contribute RMB 4.47 million, and Helex Technology will contribute RMB 10.5 million [1] Group 2 - After the establishment of the joint venture, the ownership structure will be 50.1% for the company, 14.9% for China National Machinery New Energy, and 35% for Helex Technology, making the joint venture a subsidiary of the company [1]

Group 1 - The core point of the article is that Global Medical (02666.HK) has seen a significant shareholder transfer of stock valued at HKD 1.236 billion, representing 9.37% of its shares, from GF Securities Hong Kong to Cinda International Securities [1] - Investment banks predominantly rate Global Medical as "Buy," with one bank issuing a "Buy" rating in the last 90 days and a target price of HKD 7.97 [1] - Pacific Securities has recently issued a report giving Global Medical a "Buy" rating with a target price of HKD 7.97 [1] Group 2 - Global Medical has a market capitalization of HKD 13.193 billion, ranking 5th in the healthcare services sector [1] - Key financial metrics for Global Medical compared to the industry average are as follows: ROE at 12.39% (industry average 0.02%), revenue at HKD 14.701 billion (industry average HKD 3.832 billion), net profit margin at 17.61% (industry average -843.36%), gross margin at 34.34% (industry average 39.76%), and debt ratio at 73.38% (industry average 74.15%) [1]

Group 1 - The core point of the article highlights the transfer of shares of Universal Medical (02666) from GF Securities Hong Kong to Cinda International Securities, with a market value of HKD 1.236 billion, representing 9.37% of the total shares [1] Group 2 - On November 18, 2025, the company signed an agreement to establish a joint venture with China National Machinery New Energy and Hele Technology, with a registered capital of RMB 30 million [1] - The capital contributions to the joint venture are as follows: the company will contribute RMB 15.03 million, China National Machinery New Energy will contribute RMB 4.47 million, and Hele Technology will contribute RMB 10.5 million [1] - After the establishment of the joint venture, the ownership will be distributed as follows: the company will hold 50.1%, China National Machinery New Energy will hold 14.9%, and Hele Technology will hold 35%, making the joint venture a subsidiary of the company [1]

Core Viewpoint - The establishment of a joint venture by Global Medical (02666) aims to leverage favorable policies in the Hainan Boao Lecheng International Medical Tourism Pilot Zone to expedite the registration, clinical application, and commercialization of international innovative medical devices in China [1][2] Group 1: Joint Venture Details - The joint venture agreement was signed on November 18, 2025, involving Global Medical, China Machinery New Energy (a wholly-owned subsidiary of the General Technology Group), and Hele Technology [1] - The registered capital of the joint venture is set at RMB 30 million, with contributions from the parties as follows: Global Medical will contribute RMB 15.03 million, China Machinery New Energy will contribute RMB 4.47 million, and Hele Technology will contribute RMB 10.5 million [1] - After the establishment, the ownership structure will be 50.1% for Global Medical, 14.9% for China Machinery New Energy, and 35% for Hele Technology, making the joint venture a subsidiary of Global Medical [1] Group 2: Strategic Objectives - The joint venture aims to utilize the rapid approval channels for urgently needed imported medical devices under the "National Nine Articles" framework, as well as pilot programs for real-world data applications and facilitation for foreign physicians [2] - By collaborating with management agencies, medical institutions, and industry partners, the joint venture will create a platform that integrates policy alignment, technology transfer, and clinical validation [2] - This initiative aligns with national strategies encouraging medical innovation and high-level openness, enhancing the medical device business pipeline of the company and creating long-term value for shareholders [2]

Group 1 - The core point of the news is the establishment of a joint venture between Universal Medical (02666), China National Machinery New Energy, and HeLe Technology, with a registered capital of RMB 30 million [1][2] - Universal Medical will contribute RMB 15.03 million, China National Machinery New Energy will contribute RMB 4.47 million, and HeLe Technology will contribute RMB 10.5 million, resulting in ownership stakes of 50.1%, 14.9%, and 35% respectively [1][2] - The joint venture aims to leverage the preferential policies of the Boao Lecheng International Medical Tourism Pilot Zone, facilitating rapid approval and commercialization of innovative medical devices in China [2] Group 2 - The collaboration is expected to create a platform for policy alignment, technology transfer, and clinical validation, enhancing the efficiency and commercial value of innovative medical technologies in China [2] - This initiative aligns with national strategies to encourage medical innovation and high-level openness, enriching the company's medical device pipeline and creating long-term value for shareholders [2]

Core Viewpoint - Global Medical (02666.HK) has announced the signing of an agreement to establish a joint venture with China Machinery New Energy and Hele Technology, with a registered capital of RMB 30 million [1] Group 1: Joint Venture Details - The joint venture's registered capital will be contributed in cash by the parties involved: Global Medical will contribute RMB 15.03 million, China Machinery New Energy will contribute RMB 4.47 million, and Hele Technology will contribute RMB 10.5 million [1] - After the establishment of the joint venture, ownership will be distributed as follows: Global Medical will hold 50.1%, China Machinery New Energy will hold 14.9%, and Hele Technology will hold 35% [1] - The joint venture will become a subsidiary of Global Medical [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 通用環球醫療集團有限公司 GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED ( 於香港註冊成立的有限公司 ) (股份代號： 2666) 關連交易 成立合資公司 成立合資公司 董事會欣然宣佈，於 2025年11月18日（交易時段後），本公司、中機新能（通用技術 集團間接全資附屬公司）及和樂科技簽署成立合資公司的協議。 根據協議規定，合資公司的註冊資本為人民幣3,000萬元，由相關各方以現金形式出資， 其中：(i) 本公司出資人民幣 1,503 萬元，(ii) 中機新能出資人民幣 447 萬元，及(iii) 和 樂科技出資人民幣 1,050 萬元。合資公司成立後，其註冊資本將由本公司、中機新能 及和樂科技分別持有 50.1%、14.9%及35%，合資公司將成為本公司的附屬公司。 上市規則的涵義 截至本公告日期，通用技術集團直接及間接持有本公司已發行股本約37. ...

Core Viewpoint - Universal Medical (02666) announced the appointment of Mr. Huang Youjie as a non-executive director, effective from November 17, 2025 [1] Group 1 - Mr. Huang will also serve as a member of the Board's Remuneration Committee and the Strategic and ESG Committee starting from the same date [1]

Core Viewpoint - Universal Medical (02666.HK) announced the appointment of Huang Youjie as a non-executive director, effective from November 17, 2025 [1] Company Summary - The appointment of Huang Youjie is a strategic move for Universal Medical, indicating potential future developments in governance and oversight [1]

智通财经APP讯，环球医疗(02666)发布公告，黄友杰先生(黄先生)已获委任为本公司非执行董事，该委 任自2025年11月17日起生效。 董事会谨此宣布，自2025年11月17日起，黄先生获委任为董事会薪酬委员会成员及战略与ESG委员会成 员。 ...